Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10831	Companies
235080	Keywords
163943	Articles
125843	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 10/29/2024 at 15:00, 1 year 9 months ago

Significant Positive Results with Jaguar Health's Crofelemer for Chronic Refractory Diarrhea in IBS-D, Presented at American College of Gastroenterology Annual Meeting
Napo Pharmaceuticals announces abstracts for two investigator-initiated studies on crofelemer for chronic refractory diarrhea patients, presented at ACG 2024. Jaguar CEO Lisa Conte comments on crofelemer's clinical robustness and impact on IBS-D patients

Napo Pharmaceuticals Crofelemer IBS-D Chronic Refractory Diarrhea ACG 2024
BRIEF

published on 10/16/2024 at 14:35, 1 year 9 months ago

Jaguar Health Launches Gelclair for Oral Mucositis in the U.S.

Cancer Treatment Jaguar Health Gelclair Oral Mucositis Prescription Product
BRIEF

published on 10/16/2024 at 14:35, 1 year 9 months ago

Jaguar Health lance Gelclair pour la mucosite buccale aux États-Unis

Traitement Du Cancer Santé Jaguar Gelclair Mucite Buccale Produit Sur Ordonnance
PRESS RELEASE

published on 10/16/2024 at 14:30, 1 year 9 months ago

Jaguar Health Launches FDA-Approved Oral Mucositis Prescription Product Gelclair in the U.S.
Jaguar Health, Inc. announces the commercial launch of FDA-approved oral mucositis prescription product Gelclair in the U.S. to provide pain relief for cancer patients

Jaguar Health FDA-approved Gelclair Oral Mucositis Cancer Supportive Care
BRIEF

published on 10/11/2024 at 22:20, 1 year 10 months ago

Jaguar Health Announces Employee Inducement Grants

Pharmaceuticals Jaguar Health RSUs Employee Grants Nasdaq Rule
BRIEF

published on 10/11/2024 at 22:20, 1 year 10 months ago

Jaguar Health annonce des subventions d'encouragement pour les employés

RSU Médicaments Santé Jaguar Subventions Aux Employés Règle Du Nasdaq
PRESS RELEASE

published on 10/11/2024 at 22:15, 1 year 10 months ago

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. grants restricted stock units to new employees as inducement for employment. RSUs vest over one to three years. Company focused on developing pharmaceuticals from rainforest plants for gastrointestinal distress

Restricted Stock Units Pharmaceuticals Gastrointestinal Distress Jaguar Health New Employees
BRIEF

published on 10/10/2024 at 16:05, 1 year 10 months ago

Magdalena Biosciences to Present at BIO Investor Forum

Mental Health Magdalena Biosciences Schizophrenia Market Psychoactive Drugs ADHD Treatment
BRIEF

published on 10/10/2024 at 16:05, 1 year 10 months ago

Magdalena Biosciences participera au BIO Investor Forum

Santé Mentale Biosciences De Magdalena Drogues Psychoactives Traitement Du TDAH Le Marché De La Schizophrénie
PRESS RELEASE

published on 10/10/2024 at 16:00, 1 year 10 months ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum
Magdalena plans to submit IND application in early 2025 to FDA for next-generation psychoactive drug for mental health such as ADHD and schizophrenia. Jaguar Health presents at BIO Investor Forum to discuss lead botanical drug candidate MB2500

Mental Health Jaguar Health IND Application Magdalena Psychoactive Drug

Accesswire

Published on 08/13/2026 at 14:31, 1 hour 3 minutes ago

Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity
Published on 08/13/2026 at 14:15, 1 hour 19 minutes ago

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
Published on 08/13/2026 at 14:00, 1 hour 34 minutes ago

AEONIAN Expands Koocanusa Copper Project to Approximately 412 Km(2); Fieldwork Underway Across Four New Target Areas
Published on 08/13/2026 at 14:00, 1 hour 34 minutes ago

Adcore Reports Q2 2026 Results: Gross Margin Expands to 51% as Revenue Grows 10% to CAD$7.2 million and North America Rebounds 27% to CAD$1.5 million
Published on 08/13/2026 at 14:00, 1 hour 34 minutes ago

GameSquare Appoints Tom Wild as Vice President of Creative Strategy for EMEA

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 15:15, 19 minutes ago

REINET ANNUAL GENERAL MEETING AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS APPROVES FULL AGENDA
Published on 08/13/2026 at 14:30, 1 hour 4 minutes ago

Delticom improved earnings in the first half of 2026
Published on 08/13/2026 at 14:29, 1 hour 5 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 08/13/2026 at 14:22, 1 hour 11 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 08/13/2026 at 14:20, 1 hour 14 minutes ago

Axtria to Build Industry's Largest Pharma-Specific AI Engineering Team, Scaling to 1,000 by December 2026

Les Echos

Published on 08/11/2026 at 17:45, 1 day 21 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 21 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 21 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 21 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 21 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE